PRO97 Orphan Drugs: Difference between Pharmaceutical Company Claims Versus Smr/Asmr Levels Granted through Analysis
| Autor: | Le Tohic, D., Guillot, M., Benazet, F., Diab, D., Berard, I. |
|---|---|
| Zdroj: | In Value in Health December 2020 23 Supplement 2:S707-S707 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect